Y. Prado

Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study

L. Salazar, T. Zambrano, Isis Paez, 2020, Pharmaceuticals.

Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects

L. Salazar, T. Zambrano, Y. Prado, 2018, Journal of clinical pharmacy and therapeutics.

Gender‐Specific Association Between ABCC2 ‐24C>T SNP and Reduction in Triglycerides in Chilean Patients Treated With Atorvastatin

L. Salazar, T. Zambrano, Alberto Arencibia, 2018, Basic & clinical pharmacology & toxicology.

SLCO1B1 c.388A>G Polymorphism Is Associated with HDL-C Levels in Response to Atorvastatin in Chilean Individuals

N. Saavedra, L. Salazar, T. Zambrano, 2015, International journal of molecular sciences.

MicroRNA-20a-5p Downregulation by Atorvastatin: A Potential Mechanism Involved in Lipid-Lowering Therapy

N. Saavedra, L. Salazar, K. Saavedra, 2022, International journal of molecular sciences.

CYP2C19⁎2 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls

F. Lanas, N. Saavedra, Jenny Ruedlinger, 2017, BioMed research international.

Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study

P. Loren, Luis A. Salazar, Y. Prado, 2023, Biomedicines.

MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study

N. Saavedra, L. Salazar, T. Zambrano, 2021, Frontiers in Pharmacology.